文献速递心外重症与机械循环支持

受训者经验对原位心脏移植术中缺血时间及结局的影响

Trainee experience on ischemic times and outcomes following orthotopic heart transplantation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-05-14

结果示一年级受训者的热缺血时间和主动脉阻断时间较低,而30天死亡率、原发性移植物功能障碍、因出血再手术及5年生存率在各组间无显著差异。

要点

  • 一年级受训者热缺血时间49分钟,低于二年级56.5分钟及机械循环支持/移植受训者56分钟(P=0.028)。
  • 一年级受训者主动脉阻断时间79分钟,低于二年级147分钟及机械循环支持/移植受训者143分钟(P=0.008)。
  • 30天死亡率、原发性移植物功能障碍、因出血再手术及5年生存率在各组间无显著差异。

核心结论

  • 该队列近800例手术表明,各培训年资的心脏外科受训者均可完成原位心脏移植,且短期和长期结局可接受。

研究设计与样本

  • 回顾性队列分析,纳入2011至2020年单中心所有心脏移植。
  • 排除使用器官保存系统的移植(n=10)及数据显著缺失的移植(n=37)。
  • 最终分析154例由教员外科医生完成的移植和799例由受训者完成的移植,共涉及22名受训者。

主要发现

  • 中位随访3年(IQR 1.0-5.5年),随访100%完整。
  • 受训者中位移植例数为30例(IQR 19.5-51.8)。
  • 一年级ACGME受训者热缺血时间49分钟(IQR 42-63分钟) vs 二年级受训者56.5分钟(IQR 45.5-69分钟)和机械循环支持/移植受训者56分钟(IQR 46-67分钟),P=0.028。
  • 一年级受训者主动脉阻断时间79分钟(IQR 65-100分钟) vs 二年级受训者147分钟(IQR 125-176分钟)和机械循环支持/移植受训者143分钟(IQR 119-175分钟),P=0.008。
  • 30天死亡率(4.1% [n=3] vs 2.4% [n=3] vs 2.7% [n=16];P=0.76)、原发性移植物功能障碍(5.5% [n=4] vs 4.0% [n=5] vs 4.3% [n=26];P=0.88)、因出血再手术(2.7% [n=2] vs 4.8% [n=6] vs 4.2% [n=25];P=0.78)及5年生存率(82.2%;95% CI 66.7%-84.9% vs 77.3%;95% CI 66.7%-84.9% vs 79.3%;95% CI 74.9%-83.1%;P=0.84)在各组间无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study was designed to evaluate the association of surgical training on outcomes following orthotopic heart transplantation in all levels of cardiothoracic surgery fellows. METHODS: A retrospective cohort analysis was performed on all heart transplants at a single institution from 2011 to 2020. Transplants performed using organ preservation systems (n = 10) or with significant missing data were excluded (n = 37), resulting in 154 transplants performed by faculty surgeons and 799 total transplants performed by first-year Accreditation Council for Graduate Medical Education fellows (n = 73), second-year Accreditation Council for Graduate Medical Education fellows (n = 124), or non-Accreditation Council for Graduate Medical Education fellows (n = 602) in a transplantation and mechanical circulatory support fellowship. Primary outcome was warm ischemic time analyzed by year of fellowship. Additional secondary outcomes included 30-day mortality, primary graft dysfunction, reoperation for bleeding, and 5-year survival. Median follow-up was 3 years (interquartile range [IQR], 1.0-5.5 years) and 100% complete. RESULTS: The median number of transplants performed was 30 (IQR, 19.5-51.8) during the study period performed by 22 trainees. Baseline transplant characteristics performed were similar amongst the trainee years, although the first-year Accreditation Council for Graduate Medical Education fellows approached significantly fewer re-do transplants (1.4% vs 8.1% and 4.3%; P = .07). Warm ischemic time was lower in the first-year fellows (49 minutes; IQR, 42-63 minutes) versus second-year fellows (56.5 minutes; IQR, 45.5-69 minutes) and mechanical circulatory support/transplant fellows (56 minutes; IQR, 46-67 minutes) (P = .028). Crossclamp time was also lower in the first-year fellows than in second-year and mechanical circulatory support/transplant fellows, respectively (79 minutes; IQR, 65-100 minutes vs 147 minutes; IQR, 125-176 minutes and 143 minutes; IQR, 119-175 minutes) (P = .008). Secondary outcomes, including 30-day mortality (4.1% [n = 3] vs 2.4% [n = 3] vs 2.7% [n = 16]; P = .76), primary graft dysfunction (5.5% [n = 4] vs 4.0% [n = 5] vs 4.3% [n = 26]; P = .88), reoperation for bleeding (2.7% [n = 2] vs 4.8% [n = 6] vs 4.2% [n = 25]; P = .78), and 5-year survival (82.2%; 95% CI, 66.7%-84.9% vs 77.3%; 95% CI, 66.7%-84.9% vs 79.3%; 95% CI, 74.9%-83.1%; P = .84) were comparable in all groups. CONCLUSIONS: This cohort of nearly 800 operations demonstrates that orthotopic heart transplantation may be performed by cardiac fellowship trainees all levels of training with acceptable short- and long-term outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Roach A, Trento A, Peiris A, et al. Trainee experience on ischemic times and outcomes following orthotopic heart transplantation. J Thorac Cardiovasc Surg. 2022. PMID: 35764463. doi:10.1016/j.jtcvs.2022.05.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。